J.B. Chemicals shareholders approved the amalgamation scheme with Torrent Pharmaceuticals via NCLT-convened meeting on April 28, 2026.
The resolution passed with 99.02% of equity shareholders by number and 100% by value voting in favor of the merger.
Public shareholders voted overwhelmingly in favor with 99.02% approval, meeting SEBI's majority of minority requirement.
Scrutinizer Rajesh Parekh confirmed compliance with Section 230(6) of Companies Act and SEBI Master Circular requirements.